Localization of filaggrin in human middle ear cholesteatoma

Comparative analysis of the expression of involucrin, filaggrin and cytokeratin 4, 10, 16 in cholesteatoma

Background and Objectives

The aim of this study is to determine whether the hyperproliferative and hyperkeratotic characters of cholesteatoma are associated with differentiation of keratinocytes in cholesteatoma by examining the localization of marker proteins, such as involucrin, filaggrin, and cytokeratins.

Materials and Methods

Immunohistochemical study was carried out in 30 cholesteatoma tissues and 10 retroauricular skins to examine the expression of involucrin, filaggrin, cytokeratin 4, 10 and 16. The staining results were graded as negative, weakly positive (<10%), moderately positive (10-70%), and strongly positive (>70%).

Results

Involucrin was strongly expressed in upper spinous, granular, and corneal layer of cholesteatoma. Filaggrin was strongly expressed in granular and corneal layer of cholesteatoma. Cytokeratin 4 was expressed in basal layer of retroauricular skin, but occasionally expressed in suprabasal layer of cholesteatoma. Cytokeratin 10 was homogenously expressed in all suprabasal layer of retroauricular skin, whereas pattern of shift to surface layer was showed in cholesteatoma. Cytokeratin 16 was moderately expressed at suprabasal layer in cholesteatoma.

Conclusions

It can be suggested that early differentiation of suprabasal layer may lead to hyperdifferentiation and hyperkeratosis. Different expression of cytokeratins possibly indicates the altered differentiation of cholesteatoma.

Carrier status for the common R501X and 2282del4 filaggrin mutations is not associated with hearing phenotypes in 5,377 children from the ALSPAC cohort

BACKGROUND

Filaggrin is a major protein in the epidermis. Several mutations in the filaggrin gene (FLG) have been associated with a number of conditions. Filaggrin is expressed in the tympanic membrane and could alter its mechanical properties, but the relationship between genetic variation in FLG and hearing has not yet been tested.

METHODOLOGY/PRINCIPAL FINDINGS

We examined whether loss-of function mutations R501X and 2282del4 in the FLG gene affected hearing in children. Twenty eight hearing variables representing five different aspects of hearing at age nine years in 5,377 children from the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort were tested for association with these mutations. No evidence of association was found between R501X or 2282del4 (or overall FLG mutation carrier status) and any of the hearing phenotypes analysed.

CONCLUSIONS/SIGNIFICANCE

In conclusion, carrier status for common filaggrin mutations does not affect hearing in children.

Antigen expression of epithelial markers, collagen IV and Ki67 in middle ear cholesteatoma. An immunohistochemical Study

The expression of epithelial markers (cytokeratins, Filaggrin, BerEp4 and EMA), collagen IV and Ki67 was studied immunohistochemically in cholesteatoma and compared with that in epidermis of meatal skin, squamous epithelium of eardrum and simple epithelium of middle ear mucosa. MNF116 (cytokeratin 10, 17, 18) stained the full layer of normal epithelium and all cholesteatoma specimens. CK10 and Filaggrin were expressed in the upper layer of epidermis but more diffusely in cholesteatoma. BerEp4 was found in the basal layer of normal epithelium but was detected in most epithelial cells in cholesteatoma matrix. Variability was observed in EMA and CK14 immunostaining. Collagen IV was localized in the basement membrane of normal epithelium with a continuously staining pattern, an observation also made in the cholesteatomas studied. However, in one of these small areas the basement membrane was not stained with collagen IV. Ki67 was expressed in nuclei of the cells in the basal layer of normal epithelium but extended to epithelial cells in the upper layers of cholesteatoma matrix. The results of the present study indicate that the expression pattern of epithelial markers in cholesteatoma corresponds to that in normal epidermis. The increasing expression of BerEp4 and Ki67 confirms the hyperproliferative nature of cholesteatoma. Whether or not the lack of expression of collagen IV in one of the cholesteatomas reflects a true degradation of the basement membrane needs further investigation in extended materials.

Cytoskeletal polypeptides: cell-type specific markers useful in investigative otorhinolaryngology

In the last decade, it has been established that eukaryotic cells possess a cytoskeleton, i.e. an integrated cytoplasmic network of microfilaments (MFs), microtubules (MTs) and intermediate filaments (IFs). Moreover, certain cell membrane specializations as well as the inner lamina of the nuclear membrane also participate in the cytoskeletal structure. Although this definition of the cytoskeleton is up to date it is obvious that the future course of cell biology will be reflected in a revised definition. While the bulk of structural polypeptides involved were characterized at regular intervals, surprisingly, the function of the cytoskeleton remained largely speculative and is still less precisely defined. The most widely postulated function concerns mechanical support and integration of diverse cellular activities and thus refers to cellular architecture. Briefly, the mechanical function is thought to involve cell movement, adhesive interaction with the extracellular matrix and neighbouring cells, as well as the stabilization of cell shape. The integrative function refers to intracellular movement, i.e. transport and positioning to the appropriate locations of organelles, intracellular particles, RNA and proteins. It has been established from numerous investigations that (certain) cytoskeletal polypeptides provide significant information about the cellular origin and differentiation state. This consideration constitutes the most prominent reflection underlying this review. Furthermore, this appreciation encourages additional efforts to explore these markers in normal and pathological conditions. The first purpose of this review is briefly to summarize our present comprehension of the molecular components of the cytoskeleton, restricted to the filamentous trinity for practical reasons. The second and main aim is to survey the field with respect to otorhinolaryngology-related issues. To the author's knowledge, this has not been dealt with in the past. In bridging this gap in the literature, I hope to provoke additional interest in one of the fastest moving areas of cell biology. A comprehensive review covering the whole cytoskeleton has been covered by Preston et al. (The Cytoskeleton and Cell Motility. Blackie, Glasgow and London, 1990, pp. 7-69, 188-191). Additional information on the participating substructures is provided in the text, inclusive of last year's reviews.

A comparative study of enzyme histochemical features in the gerbilline and human cholesteatoma

Spontaneous and experimentally induced cholesteatoma in the Mongolian gerbil has been found to exhibit histopathological similarities to human aural cholesteatoma and has been suggested as an experimental model for studies of the clinical situation. In an attempt to further characterize this model, we compared experimentally induced cholesteatomas in the external auditory canal from gerbils with those of the human ear by means of a correlated histopathologic and enzyme histochemical study. The human and gerbilline cholesteatomas revealed similar histopathologic features. Even enzyme histochemically, the human and experimentally induced cholesteatomas demonstrated similar features. Thus glucose-6-phosphate dehydrogenase activity, an indicator of oxidative metabolism, was demonstrated especially in the stratum granulosum cells of the heavily orthokeratinizing squamous epithelium adjacent to the cholesteatomas. The human ear canal skin also revealed enzyme histochemical characteristics similar to the squamous epithelium lining the human cholesteatoma. The hydrolytic enzyme activity (leucyl-aminopeptidase) was strong in the connective tissue surrounding human cholesteatoma when compared with that of ear canal skin. In the gerbilline cholesteatoma, this activity was demonstrated especially in the connective tissue adjacent to eroded bone, which possibly may facilitate cholesteatoma progression. We conclude that experimentally induced cholesteatoma has both histophatological and enzyme histochemical similarities to human aural cholesteatoma and therefore it is suggested that the gerbilline model may be used for studies on the development of human cholesteatoma. Our results support the view that cholesteatoma may originate from migrated hyperkeratinizing cells from the epidermis of the tympanic membrane or the meatus.